The current trend towards introduction of total quality management in laboratory medicine means that objective quality goals must be clearly defined a priori,' Objective selection and evaluation of analytical systems require that quality goals are available for preparation of specifications, appraisal of options and evaluation of experimental data? and a comprehensive internal quality control programme can be instituted only if the quality it is intended to guarantee is clearly defined.' Furthermore, adherence to the principles of good laboratory practice and participation in accreditation schemes demand that laboratories take part in external quality assessment schemes (EQAS), the best of which use well-defined quality goals as criteria for acceptable performance."
It is therefore vital that quality goals be set for all analytical performance characteristics, particularly precision and bias. Recently, the advantages and disadvantages of the various approaches available have been examined in detail and we and others have concluded that they are best based on biological variation.V
PROBLEMS WITH CURRENT RECOMMENDATIONS BASED ON BIOLOGY
An obvious problem with the ubiquitous adoption of quality goals based on biological variation is that some seem too stringent because they cannot be easily achieved with current methodology and technology; quantities requiring such goals include serum sodium, chloride and calcium, which have small biological variation. Other related analytical problems have been addressed by Stockl.? A variety of strategies could deal with this situation. Analyses which do not meet these goals Correspondence: Dr Callum G Fraser. 8 could be dropped from the repertoire of the laboratory, or sent to another laboratory. The assays could be done in replicate in separate runs to reduce the imprecision by a factor ofn 1 / 2 , where n is the number of replicates. The laboratory could decide that, even though goals were not met, the analyses still provided information of clinical value. The limitations could be overcome simply by stating that, if the quality goals are too strict, they should be viewed as targets worthy of attainment in the future." Other quality goals could be adopted, for example, the criteria used in EQAS, but the most objective proposals to date are the guidelines proposed by a Working Group of the European Group for the Evaluation of Reagents and Analytical Systems in Laboratory Medicine (EGE-Lab)9 which detailed interim specifications based upon the state-of-the-art attained by the top 0·20 fractile of laboratories on the basis that, if this significant proportion of laboratories can achieve such standards, the methodology and technology exist to allow all to achieve these. However, the state-of-the-art changes with time and, in consequence, derived quality goals will also change. Moreover, the state-of-the-art simply shows what can be currently achieved and is not based upon theoretical or practical considerations, i.e. how laboratory test results are used clinically.
In contrast, some specifications appear rather loose because they are easily surpassed with current techniques; such quantities include serum bilirubin, triglycerides and creatine kinase which have large biological variation. Again, a variety of approaches could be adopted. The laboratory could let performance decay to an inferior standard but one which appeared to allow the quality goals to be met. Quality goals based on other strategies could be adopted, for example, the criteria used in EQAS. The laboratory could realize that achievement of 
NEW PROPOSALS
performance much better than the quality goals had considerable advantages and that, for example, fewer internal quality control samples require to be assayed and less stringent quality control rules need to be applied, thereby saving considerable resources. All of the suggestions for dealing with those quantities for which the currently proposed specifications appear either too stringent or too loose seem to have advantages and disadvantages. We therefore considered that the proposal for basing quality goals on biology required further analysis to cater for these very common situations. FIGURE 
I. The percentage increase in test result variability as a function of the ratio of analytical imprecision to within-subject biological variation.
test result variability when CVA is different fractions ofCV I and these have been tabulated.P Moreover, a graphical representation of the variability added when CVA is different fractions ofCV I has been published'? and a modified form of this is shown in Fig. I .
The concept that the maximum acceptable bias is less than one-quarter of the group [within-plus between-subject] biological variation, that is [B A ] < 0·25 [CVt + CV~F/2, in order that common reference intervals can be used throughout a geographical area homogeneous for a population, was first advocated by Gowans et al. 14 The basis for this recommendation was that, when the 120 population sample size recommended by the International Federation of Clinical Chemistry'> was selected, then this was the maximum bias allowable to achieve the maximum acceptable percentage of the population outside each limit for the 0·90 confidence interval of each of the reference limits (x ±1·96 standard deviations), namely 4·4%. Different fractions of the group biological variation make for different maximum percentages of the population outside the lower and upper reference limits and these are shown graphically in Fig. 2 .
We propose that three levels of quality goals based solely on biology be considered. FIGURE 2. The percentage increase in the population outside each reference limit as a function of the ratio of bias to group biological variation. A positive bias will increase the percentage outside the upper reference limit and decrease the percentage outside the lower reference limit. A negative bias will have the same effects but on the opposite reference limits. l:i .£:
The concept that tolerable analytical variation should be less than one-half the average biological variation was first proposed by Cotlove et al. lo The statistical basis was elaborated by Harris!' who showed that, if the analytical coefficient of variation [CVA] was less than one-half the average within-subject variation [CVIl, i.e. CVA <0·50 CV I , then the amount of variability added to true test result variability through random analytical variation was less than about 10% [11'8%], which was stated to be 'reasonable'. It is important to note the empirical nature of the original fraction chosen 10 [and of any other fraction selected]. It is simple to calculate the amount of variability added to
Allowable imprecision
Examination of Fig. 1 shows that as the analytical imprecision gets bigger relative to the within-subject biological variation, the total test result variability increases. It would probably be widely accepted, even subjectively, that analytical imprecision should not be greater than biological variation. Moreover, it would probably be generally agreed that there is little merit in having imprecision any smaller than that which would contribute negligibly to biological variation. When CVA<0·75 CV 1 then at most 25% variability is added to test result variability; when CVA<0·50 CV 1 then less than 12% variability is added to test result variability and when CVA< 0·25 CV 1 then a maximum of 3% variability is added. We therefore empirically propose that, as at present, desirable performance is defined by CV A< O'50 CVI and that the quality goals generated be viewed as being generally applicable, optimum performance is defined by CVA<0·25 CV 1 and that the more stringent quality goals generated using this formula be used for those quantities for which the desirable performance standards are easily achieved with current technology and methodology, and minimum performance is defined by CVA< 0·75 CV 1 and that the less stringent quality goals generated using this formula be used for those quantities for which the desirable performance standards are not attainable with current technology and methodology.
Allowable bias
In an analogous manner, examination of Fig. 2 shows the maximum percentage outside each reference limit for different ratios of bias to group biological variation. It can be calculated that when [ 
MERITS OF OUR PROPOSAL
The quality specifications proposed here are based on biology and, as has been stated previously.s these approaches have significant advantages over all others including the attributes that estimates of biological variation are readily available'v" and seem generally independent of study locale, number and age of subjects studied, time span of study, and analytical methodology. These quality goals provide a generally applicable concept although, for specific clinical situations in which a quantity is measured for a particular clinical purpose, goals based on critical numerical analysis of the effects of error on test result interpretation may have advantages." the disadvantages of this approach are that tests are usually requested for a variety of medical reasons and, even when used in a single situation, quality goals derived from analysis of the situation do depend on the assumptions made about decision-making.P An important feature of the proposal is that the goals form a continuum which allows for making the acceptable quality goals more stringent with time. For any quantity, we consider that the minimum quality goals should always be achieved; we think that these are more appropriate than the previously proposed interim specifications based on the state of the art.? However, it must be recognized that these minimum quality specifications are not to be taken as widely applicable criteria of acceptability. More generally, and for most quantities at the present time, the well advocated, cited and used quality goals for imprecision and bias based on one-half of the within-subject variation and one-quarter of the group variation respectively, still seem most appropriate since they do indeed relate directly to the clinical uses of tests, namely, keeping the variability low so as to facilitate monitoring individuals?' and allowing the use of common reference intervals.F For the first time, to our knowledge, more stringent quality goals based on biology, our 'optimum goals', are detailed in numerical format for quantities for which the desirable quality goals are easily achieved at the present time.
For a few quantities, homeostatic regulation is very tight, for example, for serum sodium and calcium, and all of the above quality goals based on biological variation will be unattainable with any current analytical system." In practice, therefore, it may be that the realistic minimum quality goals for the performance characteristics for any quantity should be I %; this is not to say that our concept is invalid because the aim should be to achieve the goals based on biological variation in the fullness of time.
It must be clearly recognized that allowable imprecision and bias are related;' when the imprecision is large, the allowable bias must be reduced, and, similarly when there is significant inherent bias, the allowable imprecision must be made smaller. Laboratories should use numerical analysis to consider their experimentally determined performance characteristics and assess a number of quality aspects, for example, which analyses require improvement.
We believe that it would be advantageous to consider the three proposed stages as tiers of increasing analytical quality. Quantities should not be allocated to one of the classes for all time but the allocation should change as advances in quality occur with analytical improvement. Quantities for which the minimum goals are appropriate at the present time might, with considerable advantage, be reclassified into quantities for which desirable goals would be appropriate when technological or methodological advances allowed such progression. Similarly, quantities for which desirable goals are appropriate at present might be reconsidered at some future time as quantities for which optimum goals were more suitable.
We also believe that it is important for harmonization of concepts in laboratory medicine to occur not only in Europe (as is occurring at present) but all over the world; the quality goals detailed here could be used in all countries. The class of goal selected as the appropriate criterion for any particular quantity could perhaps be determined locally, after due consideration of the staff, equipment and technical resources available. National professional bodies or EQAS organizers might be appropriate groups to lead the wide introduction of such goals.
APPLICAnON OF THE GOALS
The goals proposed could be used in the introduction of new methodology, technology Setting quality goals 11 and analytical systems for setting specifications for the selection and tender processes, for critical evaluation of literature and option appraisal, and for assessment of the wealth of data generated during a comprehensive evaluation or a shorter assessment prior to adoption for routine use. We believe that the goals proposed here are an advance on those proposed previously by EGE-Lab,9 first, because they are wholly based on biology rather than partly on the state of the art and, secondly, because they have three classes rather than merely the two class system comprising desirable and interim specifications.
Modem internal quality control theory would suggest that the performance characteristics of each analytical process should be measured, the quality goals should be defined, and the number of quality control analyses and the control rules calculated so as to provide a system which guarantees the quality required;' this process is facilitated by use of the OPSpecs charts and Validator program recently developed by Westgard et al. 23 ,24 It has been proposed-' that, for EQAS in which a single sample is circulated as the challenge and analysed once, that the acceptability criteria should be calculated from the desirable precision and bias as 1·65 [0,5 eVil + 0·25 levi + eVbp/2. Although we prefer schemes which challenge precision and bias separately, a set of guidelines can be calculated using the concepts outlined here to generate specifications for use in simple single challenge EQAS based upon 1·65 [xCVd +Y levi+ evbP/2 where x and yare the appropriate fractions [0'25, 0·50 or 0·75 and 0·125,0·250 or 0'375, respectively].
Recently, Thienpont et al. 26 recommended quality goals for reference methods based solely on biology. The proposal here means that we can recommend generally applicable quality goals for the performance characteristics of routine laboratory tests also based solely on biology but tempered by considerations of whether the desirable goals calculated by rigid adherence to the generally accepted formulae are too strict or too loose. We hope that the proposals stimulate wide debate and discussion and urge their wide adoption until new better strategies are developed.
